Intellipharmaceutics International Inc. (IPCI)

[InTheTrenches]

Intellipharmaceutics to Present at the 18 th Annual Rodman & Renshaw Global Investment Conference

TORONTO, August 25, 2016 (GLOBE NEWSWIRE) -- Intellipharmaceutics International Inc. (Nasdaq:IPCI) (TSX:I)("Intellipharmaceutics" or the "Company"), a pharmaceutical company specializing in the research, development and manufacture of novel and generic controlled-release and targeted-release oral solid dosage drugs, today announced that the Company is scheduled to present at the 18 th Annual Rodman & Renshaw Global Investment Conference on September 13, 2016. Domenic Della Penna, Chief Financial Officer, will be presenting at 2:10 P.M. (Eastern Time) in the Lotte New York Palace Hotel in New York City.

If you are an institutional investor, and would like to attend the Company’s presentation or arrange a one on one meeting with the Company, please click on the following link (www.rodmanevents.com) to register for the conference.

The presentation may be accessed through the Investor Relations' Events and Presentations section on Intellipharmaceutics' website at www.intellipharmaceutics.com.